Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 6Melanoma 5Glioblastoma 5Lymphoma 4Breast Neoplasms 4Recurrence 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia 3Glioma 3Carcinoma, Ovarian Epithelial 3Rectal Neoplasms 2Prostatic Neoplasms 2Neuroblastoma 2Neoplasms 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Leukemia, Myelomonocytic, Chronic 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Brain Neoplasms 2Advanced Malignant Solid Tumor 2Xanthomatosis, Cerebrotendinous 1Wilms Tumor 1Vaccinia 1

Interventions

Tamoxifen 2Specimen Handling 2Neoadjuvant Therapy 2poly ICLC 1pasireotide 1liposomal doxorubicin 1exemestane 1Vorinostat 1UAB 30 1Surgical Procedures, Operative 1Sulindac 1Selective Estrogen Receptor Modulators 1Ritonavir 1Petrolatum 1Letrozole 1Immunohistochemistry 1Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Biopsy 1Bexarotene 1Atorvastatin 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoma, Intraductal, Noninfiltrating × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT04144023 2026-03-05

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Mayo Clinic

Phase 1 Recruiting
43 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡